For multiple myeloma, CAR T-cell therapy most commonly targets the ... The entire process involved in getting CAR T-cell ...
Through interviews and articles infused with expert insight, progress against this cancer that develops in the bone marrow ...
A GSK medicine that was pulled from the market after failing its confirmatory test in multiple myeloma has new data from a Phase 3 study evaluating it as an earlier line of treatment, and the ...